[PubMed] [Google Scholar] 8

[PubMed] [Google Scholar] 8. EIAs for detecting anti\GBM IgG antibody with those using the standard IFA method using cells from human being kidney. Thirty\two individuals with suspected Goodpasture syndrome, and 10 control sera were included in the study. GBM EIAs were purchased from or donated by the following vendors: Scimedx Corporation (Denville, NJ), INOVA Diagnostics (San Diego, CA), The Binding Site (Birmingham, England), and Wieslab (distributed by DiaSorin, Inc., Stillwater, MN). Percent agreement, level of sensitivity, and specificity were calculated for each EIA as compared to IFA. The results were as follows: Binding Site: 83.3, 100.0, and 72.0%; Wieslab: 95.2, 94.1, and 96.0%; INOVA: 96.2, 100.0, and 92.3%; and Scimedx: 81.0, 100.0, and 68.0%. We conclude GW806742X the INOVA and Wieslab GBM IgG EIAs compared well with GW806742X the standard GBM IFA method using cells from human being kidney. The Scimedx and Binding Site EIAs experienced eight and seven false\positive results, respectively, when compared to GBM IFA using human being kidney. The authors recommend conducting thorough evaluations of EIAs that display for anti\GBM antibody before their implementation in the medical laboratory. We also recommend confirming GBM EIA\positive sera by the standard IFA method using cells from human being kidney. J. Clin. Lab. Anal. 16:143C145, 2002. ? 2002 Wiley\Liss, Inc. Keywords: glomerular basement membrane (GBM), Goodpasture syndrome, IgG, autoimmune kidney disease, enzyme immunoassay (EIA), indirect fluorescent antibody (IFA) Referrals 1. Saus J, Wieslander J, Langeveld JP, Quinones S, Hudson BG. 1988. Recognition of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 263:13374C13380. [PubMed] [Google Scholar] 2. Wieslander J. 1990. The Goodpasture antigen. Contrib Nephrol 80:56C67. [PubMed] [Google Scholar] 3. Weber M, Pullig O, Kohler H. 1990. Distribution of Goodpasture antigens within numerous human basement membranes. Nephrol Dial Transplant 5:87C93. [PubMed] [Google Scholar] 4. Derry CJ, Pusey CD. 1994. Cells\specific distribution of the Goodpasture antigen shown by 2\D electrophoresis and western blotting. Nephrol Dial Transplant 9:355C361. [PubMed] [Google Scholar] 5. Mattay RA, Bromberg SI, Putman CE. 1980. Pulmonary renal syndromesa review. Yale J Biol Med 53:497C523. [PMC free article] [PubMed] [Google Scholar] 6. Adolescent KR Jr. 1989. Pulmonary\renal syndromes. Clin Chest Med 10:655C675. [PubMed] [Google Scholar] 7. GW806742X Tarantino A, Barbiano di Belgiojoso G, Durante A, Imbasciati E, Bazzi C. 1973. Immuno\histological characterization of glomerular nephropathies evaluated by direct and indirect methods. Minerva Nefrol 20:199C210. [PubMed] [Google Scholar] 8. Schneider W, GW806742X Manger T, Porstmann T. 1986. Immunologic analysis of glomerulonephritis by basement membrane antibodies. Z Urol Nephrol 79:53C57. [PubMed] [Google Scholar] 9. Savage CO, Noel LH, Crutcher E, Price SR, Grunfeld JP, Lockwood CM. 1989. Hereditary nephritis: immunoblotting studies of the glomerular basement membrane. Lab Invest 60:613C618. [PubMed] [Google Scholar] Rabbit Polyclonal to MC5R 10. Weber MF, Andrassy K, Pullig O, Koderisch J, Netzer K. 1992. Antineutrophil\cytoplasmic antibodies and antiglomerular basement antibodies in Goodpastures syndrome and Wegeners granulomatosis. J Am GW806742X Soc Nephrol 2:1227C1234. [PubMed] [Google Scholar].